Updated Nov. 17, 2012 at 10:51 a.m.

Premium Lock Tranzyme shares plunge another 16% after drug failure

Published: 2012-11-16 10:22:00
Updated: 2012-11-17 10:51:08

Print this blog post
Transzyme

Shares in Tranzyme Pharma plummeted 76 percent Thursday and another 16 percent after the RTP-based company announced failure of a drug that it hoped would treat diabetics suffering from gastroparesis....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll